Cargando…

P577: EFFICACY OF SELINEXOR COMBINED WITH A HYPOMETHYLATING AGENT IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA IN PATIENTS EXPOSED TO VENETOCLAX

Detalles Bibliográficos
Autores principales: Zhang, Jian, Song, Baoquan, Kong, Xin, Liu, Yin, Yang, Hanlin, Qiu, Huiying, Wu, Depei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429370/
http://dx.doi.org/10.1097/01.HS9.0000969212.99205.d9
_version_ 1785090695856390144
author Zhang, Jian
Song, Baoquan
Kong, Xin
Liu, Yin
Yang, Hanlin
Qiu, Huiying
Wu, Depei
author_facet Zhang, Jian
Song, Baoquan
Kong, Xin
Liu, Yin
Yang, Hanlin
Qiu, Huiying
Wu, Depei
author_sort Zhang, Jian
collection PubMed
description
format Online
Article
Text
id pubmed-10429370
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104293702023-08-17 P577: EFFICACY OF SELINEXOR COMBINED WITH A HYPOMETHYLATING AGENT IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA IN PATIENTS EXPOSED TO VENETOCLAX Zhang, Jian Song, Baoquan Kong, Xin Liu, Yin Yang, Hanlin Qiu, Huiying Wu, Depei Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429370/ http://dx.doi.org/10.1097/01.HS9.0000969212.99205.d9 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Zhang, Jian
Song, Baoquan
Kong, Xin
Liu, Yin
Yang, Hanlin
Qiu, Huiying
Wu, Depei
P577: EFFICACY OF SELINEXOR COMBINED WITH A HYPOMETHYLATING AGENT IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA IN PATIENTS EXPOSED TO VENETOCLAX
title P577: EFFICACY OF SELINEXOR COMBINED WITH A HYPOMETHYLATING AGENT IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA IN PATIENTS EXPOSED TO VENETOCLAX
title_full P577: EFFICACY OF SELINEXOR COMBINED WITH A HYPOMETHYLATING AGENT IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA IN PATIENTS EXPOSED TO VENETOCLAX
title_fullStr P577: EFFICACY OF SELINEXOR COMBINED WITH A HYPOMETHYLATING AGENT IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA IN PATIENTS EXPOSED TO VENETOCLAX
title_full_unstemmed P577: EFFICACY OF SELINEXOR COMBINED WITH A HYPOMETHYLATING AGENT IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA IN PATIENTS EXPOSED TO VENETOCLAX
title_short P577: EFFICACY OF SELINEXOR COMBINED WITH A HYPOMETHYLATING AGENT IN THE TREATMENT OF REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA IN PATIENTS EXPOSED TO VENETOCLAX
title_sort p577: efficacy of selinexor combined with a hypomethylating agent in the treatment of refractory/relapsed acute myeloid leukemia in patients exposed to venetoclax
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429370/
http://dx.doi.org/10.1097/01.HS9.0000969212.99205.d9
work_keys_str_mv AT zhangjian p577efficacyofselinexorcombinedwithahypomethylatingagentinthetreatmentofrefractoryrelapsedacutemyeloidleukemiainpatientsexposedtovenetoclax
AT songbaoquan p577efficacyofselinexorcombinedwithahypomethylatingagentinthetreatmentofrefractoryrelapsedacutemyeloidleukemiainpatientsexposedtovenetoclax
AT kongxin p577efficacyofselinexorcombinedwithahypomethylatingagentinthetreatmentofrefractoryrelapsedacutemyeloidleukemiainpatientsexposedtovenetoclax
AT liuyin p577efficacyofselinexorcombinedwithahypomethylatingagentinthetreatmentofrefractoryrelapsedacutemyeloidleukemiainpatientsexposedtovenetoclax
AT yanghanlin p577efficacyofselinexorcombinedwithahypomethylatingagentinthetreatmentofrefractoryrelapsedacutemyeloidleukemiainpatientsexposedtovenetoclax
AT qiuhuiying p577efficacyofselinexorcombinedwithahypomethylatingagentinthetreatmentofrefractoryrelapsedacutemyeloidleukemiainpatientsexposedtovenetoclax
AT wudepei p577efficacyofselinexorcombinedwithahypomethylatingagentinthetreatmentofrefractoryrelapsedacutemyeloidleukemiainpatientsexposedtovenetoclax